Doctors in Chicago are testing immersive technology as part of a new clinical trial that could change how colon cancer is detected—and potentially expand to hospitals nationwide.

New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.

According to Rush University Medical Center, the Division of Digestive Diseases is using an application built by Cosmo ...

Individuals with two HNPCC-associated cancers a including synchronous and metachronous colorectal cancers or associated extracolonic cancers Individuals with colorectal cancer and a first-degree ...

The American Cancer Society says an uptick in colon cancer cases in the 45-49 age group is a result of lowered screening ages leading to earlier detection. Photo by Adobe Stock/HealthDay There's been ...

SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — New global initiative urges patients and clinicians to wait for biomarker testing results ...